首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PHIMOSIVE WITH A TOPICAL CORTICOSTEROID

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PHIMOSIVE WITH A TOPICAL CORTICOSTEROID

机译:糖皮质激素类药物治疗药物的药物组合物

摘要

This invention addresses the pharmaceutical composition for topical corticosteroid use in association with diffusing enzyme for treatment of phimosis. A pharmaceutical composition for treatment of phimosis using topical corticosteroid characterized by including around 0.025 to 5 percent in weight in relation to the total weight of the mixture composition of one or more corticosteroids and/or hormone steroids, whether or not associated with non-hormonal anti-inflammatory agents and around 25 UTR to 4000 UTR/g of one or more proteolytic diffusing enzymes in proper medium, in different pharmaceutical forms, accompanied with additives known to the technical man. Topical corticosteroid application in association with diffusing enzyme for treatment of phimosis in which 90 percent of the patients had improvements over their clinical complaints, with the prepuce being easily retracted.
机译:本发明涉及用于局部皮质类固醇与扩散酶联合治疗包茎的药物组合物。一种使用局部皮质类固醇治疗包茎的药物组合物,其特征在于相对于混合物组合物的总重量,包括约0.025至5%的一种或多种皮质类固醇和/或激素类固醇,无论是否与非激素抗-炎症剂和大约25 UTR至4000 UTR / g的一种或多种蛋白水解扩散酶在适当的介质中以不同的药物形式,以及技术人员已知的添加剂。局部使用皮质类固醇与扩散酶联用治疗包茎病,其中90%的患者对临床不适有所改善,包皮过长容易收回。

著录项

  • 公开/公告号DE60121047T2

    专利类型

  • 公开/公告日2007-06-21

    原文格式PDF

  • 申请/专利权人 APSEN FARMACEUTICA S.A.;

    申请/专利号DE2001621047T

  • 发明设计人

    申请日2001-12-13

  • 分类号A61K31/57;A61P15;A61K38/48;

  • 国家 DE

  • 入库时间 2022-08-21 20:28:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号